Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1-b]-1,3,4-thiadiazole derivatives

被引:138
作者
Gadad, AK [1 ]
Noolvi, MN [1 ]
Karpoormath, RV [1 ]
机构
[1] JN Med Coll, Coll Pharm, Dept Med Chem, Karnataka 590010, India
关键词
imidazo[2,1-b]-1,3,4-thiadiazoles; alpha-haloaryl/heteroaryl ketones; anti-tuberculax activity; BACTEC assay;
D O I
10.1016/j.bmc.2004.07.060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 2-sulfonamido/trifluoromethyl-6-(4'-substituted aryl/heteroaryl)imidazo[2,1-b]-1,3,4-thiadiazole derivatives (11) have been synthesized by reaction of 2-amino-5-sulfonamido/trifluoromethyl-1,3,4-thiadiazoles and an appropriate alpha-halo-aryl/heteroaryl ketones. Further 5-bromo (III), 5-thiocyanato (IV), 5-gaunylhydrazone (V) derivatives were synthesized in order to study the effect of these substituents on biological activity. Structures of these compounds were established by IR, H-1 NMR, C-13 NMR, Mass and HRMS. The selected compounds were evaluated for their preliminary in vitro anti-tuberculosis activity against Mycobacterium tuberculosis H37Rv strain using radiometric BACTEC and broth dilution assay methods. The results show that compounds 5, 7, 8, 10 and 12 exhibited moderate to good anti-tubercular activity with percentage inhibition of 29, 43, 58, 31 and 41, respectively, at a MIC of >6.25 mug/mL. Compound 18 showed a MIC of 20 mug/mL. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5651 / 5659
页数:9
相关论文
共 43 条
[1]   Synthesis and antitumor activity of 5-trifluoromethyl-2,4-dihydropyrazol-3-one nucleosides [J].
Abdou, IM ;
Saleh, AM ;
Zohdi, HF .
MOLECULES, 2004, 9 (03) :109-116
[2]  
ANAND N, 1996, BURGERS MED CHEM DRU, P1
[3]   Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity [J].
Barbachyn, MR ;
Hutchinson, DK ;
Brickner, SJ ;
Cynamon, MH ;
Kilburn, JO ;
Klemens, SP ;
Glickman, SE ;
Grega, KC ;
Hendges, SK ;
Toops, DS ;
Ford, CW ;
Zurenko, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :680-685
[4]   Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs [J].
Barry, CE ;
Slayden, RA ;
Sampson, AE ;
Lee, RE .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (03) :221-231
[5]   TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN [J].
BASS, JB ;
FARER, LS ;
HOPEWELL, PC ;
OBRIEN, R ;
JACOBS, RF ;
RUBEN, F ;
SNIDER, DE ;
THORNTON, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) :1359-1374
[6]   SYNTHESIS OF 1-ARYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACIDS AND ESTERS [J].
BECK, JR ;
WRIGHT, FL .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1987, 24 (03) :739-740
[7]  
Blatt AH, 1943, ORGANIC SYNTHESIS CO, V2, P480
[8]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[9]   EFFICIENT ENTRY TO PERFLUOROALKYL SUBSTITUTED AZOLES STARTING FROM BETA-PERFLUOROALKYL-BETA-DICARBONYL COMPOUNDS [J].
BRAVO, P ;
DILIDDO, D ;
RESNATI, G .
TETRAHEDRON, 1994, 50 (29) :8827-8836
[10]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009